Some LCNEC and SCLC tumors have been reported to exhibit FGFR1 amplification (Peifer et al. 2012); however, no LCNEC or SCLC tumors that were strongly positive for FGFR1 were observed in our study. The gene discussed is FGFR1; the disease is large cell neuroendocrine carcinoma.